Global biotechnology leader CSL Behring becomes title sponsor for inaugural Uplifting Athletes Young Investigator Draft


YID 18 TITLE SPONSOR GRAPHICUplifting Athletes is pleased to announce CSL Behring as the title sponsor for the 2018 Young Investigator Draft on August 18 at Lincoln Financial Field in Philadelphia.

The Young Investigator Draft, tying the theme of the NFL Draft and Rare Disease Research together, is the result of Uplifting Athletes’ ongoing commitment to cultivate resources that accelerate scientific advancements for rare disease treatments and potential cures while facilitating the next generation of rare disease researchers.

CSL Behring is a global biotechnology leader focused on serving patients’ needs. Their scientists use the latest technologies to develop and deliver innovative therapies that are used to treat rare and serious conditions, including immunodeficiency and autoimmune diseases, hereditary and acquired bleeding disorders, chronic inflammatory demyelinating polyneuropathy, hereditary angioedema and Alpha-1 antitrypsin deficiency, as well as transplantation and critical care.

“We are so fortunate to have the support of a company like CSL Behring for our inaugural event. Having such a big player in the rare disease space as our title sponsor is a tremendous honor,” Uplifting Athletes Director, Rare Disease Engagement Rob Long said. “The Young Investigator’s Draft will provide funding for inspirational, intelligent, and driven researchers in the rare disease space. The support of CSL Behring as our title sponsor shows their commitment to this as well.”

At the event, individual $10,000 grants will be given to five Young Investigators who pursue rare disease research in these five different areas: rare cancers, rare autoimmune and immunological disorders, rare blood disorders, rare genetic disorders and rare muscular and neurological disorders.

“CSL Behring is driven by its promise to develop lifesaving therapies for patients with rare and serious diseases,” said Jens Oltrogge, CSL Behring’s Head of Global Commercial Development Hematology. “We’re thrilled to sponsor this unique initiative that provides vital funding and inspiration to bright young researchers focused on rare diseases.

The Young Investigator Draft grants are intended to inspire collaborative and translational research that will benefit the entire Rare Disease Community. The Young Investigator Draft stage will provide a platform for these young scientists to educate and inspire the audience by sharing their research along with its impact on the Rare Disease Community.

Tickets are available through the Young Investigator Draft registration page. The event will include heavy hors d’oeuvres and beer and wine prior to the program for the evening.

The challenges faced by the rare disease community are bigger than any one individual, team or organization can tackle alone. At Uplifting Athletes we take pride in providing opportunity for college football student-athletes and NFL players to use the platform they are afforded to shine a spotlight on rare diseases and support the cause.

Founded in 2007, Uplifting Athletes has college football student-athlete led chapters nationwide in FBS and FCS programs including nearly half the schools in the Big Ten and ACC conferences.